Active Power, Inc. (NASDAQ: ACPW), has been invited to present at the 27th Annual ROTH Conference being held March 8-11, 2015, at the Ritz Carlton in Dana Point, Calif. On Thursday shares of Active Power Inc. (NASDAQ:ACPW) closed at $2.49. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 years is recorded as 20.00%.
On 2 March, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported Revenues totaled $9.2 million, including $3.8 million in net product sales of BELVIQ, of which $3.2 million represented 31.5% of Eisai’s net product sales and $0.6 million related to redemptions of the 15-day free voucher and product samples. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in last trading activity fell -2.08% to close at $4.23. Company weekly performance is -10.95% while its quarterly performance stands at 2.42%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is -41.57% away from its 52 week high.
Supervalu (NYSE:SVU)‘s stock had its “neutral” rating reaffirmed by Zacks in a note issued to investors on Friday. They currently have a $10.00 price objective on the stock. Zacks‘s price objective suggests a potential upside of 1.21% from the stock’s previous close.On last trading day SUPERVALU Inc. (NYSE:SVU) increased 2.26% to close at $10.41. Its volatility for the week is 2.63% while volatility for the month is 2.07%. SVU’s sales growth for past 5 years was -17.40% and its EPS growth for past 5 years was 14.90%. SUPERVALU Inc. (NYSE:SVU) monthly performance is 2.87%.
Wix.com Ltd. (NASDAQ:WIX), announced that it will host its first Analyst and Investor Day on Wednesday, March 18, 2015 in New York City. Wix.com Ltd. (NASDAQ:WIX) its institutional ownership stands at 82.80%. In last trading activity company’s stock closed at $18.30.
On 25 February, Clovis Oncology, Inc. (NASDAQ:CLVS) reported a net loss for the fourth quarter of 2014 of $54.9 million ($1.62 per share), and $160.0 million ($4.72 per share) for the year ended December 31, 2014. This compares to a net loss of $29.2 million ($0.92 per share) for the fourth quarter and $84.5 million ($2.95 per share) for the year ended December 31, 2013. On last trading day Clovis Oncology, Inc. (NASDAQ:CLVS) increased 2.92% to close at $79.66. Its volatility for the week is 5.04% while volatility for the month is 4.95%. Clovis Oncology, Inc. (NASDAQ:CLVS) monthly performance is 22.31%.